Nat Rev Microbiol 2008, 6:441–454 PubMed 2 Nemati M, Jenneman GE

Nat Rev Microbiol 2008, 6:441–454.PubMed 2. Nemati M, Jenneman GE, Voordouw G: Mechanistic study of microbial control of hydrogen sulfide production in oil reservoirs. Biotechnol Bioeng 2001, 74:424–434.PubMedCrossRef 3. Videla HA, Herrera LK: Microbiologically influenced corrosion: looking to the future. Int Microbiol 2005, 8:169–180.PubMed 4. Korenblum E, Valoni E, Penna M, Seldin L: Bacterial diversity in water injection systems of Brazilian offshore oil platforms. Appl Microbiol Biotechnol 2010, 85:791–800.PubMedCrossRef 5. Videla HA: Prevention and control of biocorrosion. Inter Biodeterd Biodegrad 2001, 4:259–270. 6. NACE International – the corrosion https://www.selleckchem.com/products/PLX-4032.html societyhttp://​www.​nace.​org/​

7. Ongena M, Jacques P: Bacillus lipopeptides: versatile weapons for plant disease biocontrol.

Trends Microbiol 2008, 16:115–125.PubMedCrossRef 8. Abriouel H, Franz CM, Ben Omar N, Gálvez A: Diversity and applications of Bacillus bacteriocins. FEMS Microbiol Rev 2011, 35:201–232.PubMedCrossRef 9. Cherif A, Chehimi S, Limem F, Hansen BM, Hendriksen NB, Daffonchio D, Boudabous A: Detection and characterization of the novel bacteriocin entomocin 9, and safety evaluation of its producer, Bacillus thuringiensis ssp. entomocidus HD9. J Appl Microbiol 2003, 95:990–1000.PubMedCrossRef 10. Hyronimus B, Le Marrec C, Urdaci MC: Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. SCH772984 mw J Appl Microbiol 1998, 85:42–50.PubMedCrossRef 11. Korenblum E, der Weid I, Santos AL, Rosado AS, Sebastián GV, Coutinho CM, Magalhães FC, Paiva MM, Seldin L: Production of antimicrobial substances by Bacillus

subtilis LFE-1, B. firmus HO-1 and B. licheniformis T6–5 isolated from an oil reservoir in Brazil. J Appl Microbiol 2005, 98:667–675.PubMedCrossRef 12. Naruse N, Tenmyo O, Kobaru S, Kamei H, Miyaki T, Konishi M, Oki T: Pumilacidin, a complex of new antiviral antibiotics. Production, isolation, chemical properties, structure and biological activity. J Antibiot (Tokyo) 1990, 43:267–280.CrossRef 13. Stein T: Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol Microbiol 2005, 56:845–857.PubMedCrossRef 14. Tagg JR, Dajani AS, Wannamaker LW: Bacteriocins of gram-positive bacteria. Bacteriol Rev 1976, 40:722–756.PubMed 15. Azuma T, Harrison Progesterone GI, Demain AL: Isolation of a gramicidin S hyperproducing strain of Bacillus brevis by use of a fluorescence activated cell sorting system. Appl Microbiol Biotechnol 1992, 38:173–178.PubMedCrossRef 16. Fujita-Ichikawa Y, Tochikubo K: Quantitative analysis of polymyxin B released from polymyxin B-treated dormant spores of Bacillus subtilis and relationship between its permeability and inhibitory effect on outgrowth. Microbiol Immunol 1993, 37:935–941.PubMed 17. Arima K, Kakinuma A, Tamura G: Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem Biophys Res Commu 1968, 31:488–494.CrossRef 18.

Comments are closed.